Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark K Walsh

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cold Spring Harbor Protocols|November 3, 2012
In vivo imaging of the developing neuromuscular junction in neonatal miceStephen G Turney, Mark K Walsh, Jeff W Lichtman
Retinal Cases & Brief Reports|November 13, 2014
Serratia marcescens endophthalmitis after 20-gauge pars plana vitrectomyDavid T Goldenberg, Abhishek Harinandan, Mark K Walsh, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Norrie disease vs familial exudative vitreoretinopathyMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Retina (Philadelphia, Pa.)|March 13, 2010
Early vitrectomy effective for bilateral combined anterior and posterior persistent fetal vasculature syndromeMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2010
Early vitrectomy effective for Norrie diseaseMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Retinal Cases & Brief Reports|November 13, 2014
Retinal detachments involving the posterior pole in hallermann-streiff syndromeMaheen Haque, David T Goldenberg, Mark K Walsh, et al.
Retinal Cases & Brief Reports|November 13, 2014
Intravitreal bevacizumab and ranibizumab for choroidal neovascularization secondary to endogenous endophthalmitisAlice M Fecko, Lawrence Y Ho, Mark K Walsh, et al.
Retina (Philadelphia, Pa.)|February 12, 2016
INDUCTION OF MACULAR DETACHMENT FOR THE TREATMENT OF PERSISTENT OR RECURRENT IDIOPATHIC MACULAR HOLESAndrei-Alexandru Szigiato, Fatimah Gilani, Mark K Walsh, et al.
Retinal Cases & Brief Reports|November 13, 2014
Hyphema after intravitreal injection of ranibizumab or bevacizumabTushar M Ranchod, Mark K Walsh, Antonio Capone, et al.
Retina (Philadelphia, Pa.)|February 14, 2014
Diagnostic and therapeutic challengesMaja Vinkovic, Gabriella De Salvo, Dubravka Biuk, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cold Spring Harbor Protocols|November 3, 2012
In vivo imaging of the developing neuromuscular junction in neonatal miceStephen G Turney, Mark K Walsh, Jeff W Lichtman
Retinal Cases & Brief Reports|November 13, 2014
Serratia marcescens endophthalmitis after 20-gauge pars plana vitrectomyDavid T Goldenberg, Abhishek Harinandan, Mark K Walsh, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 15, 2011
Norrie disease vs familial exudative vitreoretinopathyMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Retina (Philadelphia, Pa.)|March 13, 2010
Early vitrectomy effective for bilateral combined anterior and posterior persistent fetal vasculature syndromeMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2010
Early vitrectomy effective for Norrie diseaseMark K Walsh, Kimberly A Drenser, Antonio Capone, et al.
Retinal Cases & Brief Reports|November 13, 2014
Retinal detachments involving the posterior pole in hallermann-streiff syndromeMaheen Haque, David T Goldenberg, Mark K Walsh, et al.
Retinal Cases & Brief Reports|November 13, 2014
Intravitreal bevacizumab and ranibizumab for choroidal neovascularization secondary to endogenous endophthalmitisAlice M Fecko, Lawrence Y Ho, Mark K Walsh, et al.
Retina (Philadelphia, Pa.)|February 12, 2016
INDUCTION OF MACULAR DETACHMENT FOR THE TREATMENT OF PERSISTENT OR RECURRENT IDIOPATHIC MACULAR HOLESAndrei-Alexandru Szigiato, Fatimah Gilani, Mark K Walsh, et al.
Retinal Cases & Brief Reports|November 13, 2014
Hyphema after intravitreal injection of ranibizumab or bevacizumabTushar M Ranchod, Mark K Walsh, Antonio Capone, et al.
Retina (Philadelphia, Pa.)|February 14, 2014
Diagnostic and therapeutic challengesMaja Vinkovic, Gabriella De Salvo, Dubravka Biuk, et al.
Pageof 3